J. Goldman & Co’s Medtronic MDT Stock Holding History

J. Goldman & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$207K	Buy	+2,392	New	+$229K	0.01%	598
2016 Q2	–	Sell	-137,800	Closed	-$10.3M	–	385
2016 Q1	$10.3M	Buy	+137,800	New	+$10.4M	0.64%	43
2015 Q4	–	Sell	-101,902	Closed	-$6.82M	–	271
2015 Q3	$6.82M	Buy	+101,902	New	+$7.51M	0.58%	52
2014 Q4	–	Sell	-165,000	Closed	-$11.5M	–	247
2014 Q3	$10.2M	Buy	+165,000	New	+$10.5M	0.62%	41
2014 Q1	–	Sell	-221,000	Closed	-$12.7M	–	271
2013 Q4	$12.7M	Buy	221,000 +201,000	+1,005%	+$11.4M	1.59%	9
2013 Q3	$1.06M	Buy	+20,000	New	+$1.08M	0.1%	190

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

J. Goldman & Co's MDT Position: Q1 2026 in Review

J. Goldman & Co opened a new position in Medtronic (MDT) in Q1 2026: 2,392 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #598 among its holdings. This is a return to the name: J. Goldman & Co previously reported a position in MDT as recently as Q1 2016.

J. Goldman & Co first reported a position in MDT in Q3 2013 and has held it in 6 quarters since. The position peaked at $12.7M in Q4 2013. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

J. Goldman & Co held 2,392 shares of Medtronic worth $207K as of Q1 2026.
Medtronic was a new J. Goldman & Co position in Q1 2026.
Medtronic made up 0.01% of J. Goldman & Co's portfolio in Q1 2026, its #598 holding.
J. Goldman & Co first reported a position in Medtronic in Q3 2013 and has held it in 6 quarters since.
J. Goldman & Co's Medtronic position peaked at $12.7M in Q4 2013.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.